• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Wellness

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

byNancy LuandAvneesh Bhangu
October 22, 2021
in Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This quantitative study found that transgender Veterans Health Administration (VA) patients were more likely to use certain drugs than cisgender VA patients.

2. Opioid and sedative use disorder did not differ significantly between transgender and cisgender VA patients.

Evidence Rating Level: 2 (Good)

Drug use disorders in the United States (US) are a major problem, especially among vulnerable groups. One example of a vulnerable group is transgender people, defined as people whose genders are different from those assigned at birth. Few studies compare substance use disorder prevalence rates between transgender and cisgender patients, and most of these studies have been small. As the largest national provider of substance use treatment, the US Veterans Health Administration (VA) provides a large dataset to study this important question.

This retrospective quantitative study was a secondary analysis of electronic health record data from the VA Corporate Data Warehouse, which is a parent study examining patterns of alcohol use among transgender versus cisgender VA outpatients from October 1st, 2009 to July 31st,2017. Patients were included if they had a documented alcohol use disorder (n=8,872,793). Patients were excluded if they did not answer all study questions. The measured outcome variables were the documented drug use disorder diagnoses.

Amongst 8,872,793 included patients, 8619 were transgender. From the analyses, the research demonstrated that transgender VA patients were more likely to have amphetamine, cocaine, and cannabis use disorders compared to cisgender patients, but were equally likely to have opioid and sedative use disorders. Furthermore, there was no significant association with having a mental health condition. This study did have its limitations including possible misclassification of certain transgender patients as well as not distinguishing between men and women. Despite these limitations, this study furthered our understanding of struggles and barriers transgender people may face in regards to substance use disorders.

RELATED REPORTS

Cannabis use frequency increased following legalization with a decrease in misuse observed

Vertex: non-opioid pain reliever Journavx shows success in post operative pain control

Schizophrenia incidence sharply increased following cannabis legalization

Click to read the study in Journal of Addiction Medicine

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: amphetaminecannabiscisgendercocaineopioidtransgenderveteran
Previous Post

Top 10 TV Shows to Binge Watch During Lockdown

Next Post

#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

RelatedReports

Parental cannabis use increasing, cigarette use decreasing
Psychiatry

Cannabis use frequency increased following legalization with a decrease in misuse observed

May 2, 2025
Parental nonmedical prescription opioid use linked to adolescent use
Pharma

Vertex: non-opioid pain reliever Journavx shows success in post operative pain control

March 4, 2025
Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

Schizophrenia incidence sharply increased following cannabis legalization

May 19, 2025
Institute of Medicine identifies cost variation between geographic regions
Psychiatry

Communities That HEAL intervention does not reduce opioid-related mortality

October 8, 2024
Next Post
#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

Coronavirus: Warning over easing lockdown measures too quickly

For Some Trump Voters, Coronavirus Was The Last Straw

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis
  • #VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline
  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.